News

Alithya Achieves Impressive Revenue Growth and Margin Increase

Alithya Achieves Impressive Revenue Growth and Margin Increase

Alithya's Q2 Performance Overview

Alithya Group Inc. (TSX: ALYA) has released substantial results for its second fiscal quarter, showcasing strong year-over-year revenue growth and notable improvements in gross margin, which reflect the company's effective business strategies.

Financial Highlights for Q2-2026

In the second quarter, Alithya achieved revenues of $124.3 million, marking an 11.5% increase compared to last year. This indicates robust operational efficiency, as 79.8% of these revenues were derived from clients retained since the same quarter last year.

Gross Margin Expansion

The company's gross margin soared by 25.5% to reach $42.8 million, reflecting a gross margin percentage of revenues of 34.4%, a significant rise from 30.6% in the corresponding period of 2025. Such growth in gross margin showcases Alithya's commitment to enhancing its service offerings and optimizing operations.

Net Earnings and Adjustments

Despite the impressive revenue and gross margin figures, Alithya reported a net loss of $31.0 million, influenced heavily by a $38.0 million impairment charge. Adjusted net earnings climbed to $9.5 million, up 80% from $5.3 million in the same quarter last year, highlighting the effects of effective cost management strategies implemented amidst rising operational costs.

Adjusted EBITDA Performance

Adjusted EBITDA grew by $3.5 million, or 37.5%, reaching $12.8 million. This resulted in an adjusted EBITDA margin of 10.3% of revenues, up from 8.3% a year ago, demonstrating a strong control over expenditures and enhanced profitability.

Client Activity and Future Prospects

During the quarter, Alithya signed 22 new clients, further bolstering its market presence. Bookings for Q2 reached $90.9 million, with a book-to-bill ratio of 0.73 indicating a healthy pipeline for future revenues. When excluding the revenues from two long-term contracts obtained through acquisitions in previous quarters, the adjusted book-to-bill ratio would be 0.80.

Regional Revenue Insights

Regionally, Alithya experienced a 7.4% revenue decrease in Canada but more than compensated with a 34.8% increase in U.S. revenues, which amounted to $63.1 million driven by organic growth and higher billing rates. International revenues also performed well, growing by 15.7% year-over-year.

Expenditure Management and Operating Cash Flow

Selling, general, and administrative expenses increased by 20.8% to $31.3 million, primarily due to additional expenses from recent acquisitions. However, net cash from operating activities amounted to $1.1 million, showing a reduction from $3.0 million the previous year, highlighting the need for careful cash flow management moving forward.

Liquidity and Financial Position

As of the end of the quarter, Alithya had $102.3 million drawn against its credit facility, with an additional liquidity available of $108.3 million. This solid liquidity position grants Alithya the flexibility to pursue growth opportunities and navigate through the complexities of the market.

Looking Ahead

With its focus on integrating advanced technologies and enhancing service offerings, Alithya is well-positioned for future growth. The company's strategic acquisitions and expansion plans aim to capitalize on emerging business opportunities, maintaining its momentum in an increasingly competitive market.

Frequently Asked Questions

What are the main drivers of Alithya's revenue growth?

Alithya's revenue growth is attributed to increased client retention, successful acquisition integrations, and the advancement of service offerings that meet market demands.

How did Alithya's gross margin change in this quarter?

The gross margin improved significantly to 34.4%, driven by higher revenue combined with optimized operational efficiencies.

What impact did the impairment charge have?

The impairment charge of $38.0 million impacted the net loss but was counterbalanced by a substantial increase in adjusted net earnings, reflecting the underlying operational strength.

What are the expectations for future bookings?

Future bookings appear optimistic due to a healthy pipeline indicated by the book-to-bill ratio of 0.73 for the quarter and new client signings.

How is Alithya managing its operational costs?

Alithya focuses on strategic cost management through increased billing rates and enhancing service delivery efficiency to mitigate rising operational expenses.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 0

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Backroads Invites Families: Adventures Boost Bookings by 20%

Updated Category News Views 8

Rediscovering Family Time Through Adventure When was the last time a winter vacation got you this fired up? Backroads, the trailblazer in active getaways, is bucking the trend of typical holiday madness. Families are ditching the usual gift-giving grind for something way more memorable: experiences that blend action with bonding across generations. Big Numbers, Big...

Continue Reading
Epilepsy Market's Explosive Growth Forecasted to 2036

Updated Category News Views 12

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

Continue Reading
Antibiotic Overuse for Sinus Infections Costs Billions

Updated Category News Views 21

Sinus Infections: A Case of Excess Prescriptions You'd think with all the guidelines, doctors would've nailed the sinusitis treatment by now. But nope—antibiotic overuse remains alive and kicking. A fresh dig from Motive Medical Intelligence shows that more than three-quarters of primary care clinicians are quick to hand out antibiotics for acute sinusitis. So here we...

Continue Reading
Energy Fuels Secures Key Financing for Donald Project

Updated Category News Views 178

Donald Project: A Step Closer to Reality Look, when those rare earths start moving, the entire market gets a whiff of promise. Energy Fuels' Donald Rare Earth and Mineral Sands Project in Australia is gearing up for real action with a fresh funding nod. Export Finance Australia and the National Reconstruction Fund Corporation have conditionally greenlit up to A$180...

Continue Reading
Americans' Faith in Democracy Hits New Lows

Updated Category News Views 0

Polarization Beyond Politics: A National Reckoning When you catch wind of a report like this one, it's enough to make you feel like the fabric of democracy is unraveling right before our eyes. We're staring at a national identity crisis, folks, and it's got nothing to do with whether you're waving a red or blue flag. This ain't about party lines; it's about a bigger,...

Continue Reading
Pii's Odyssey Ignites Epic Cosmic Adventure

Updated Category News Views 113

A Cosmic Journey Begins Well, here's a fresh start to a galactic escapade or two! LaMont Schiers, with his brain teeming post a vivid dream, plunges headfirst into the science fiction scene. 'Pii's Odyssey: The Eternals' isn't your average bedtime read. Oh no, this is where a 14-year-old warrior kid named Pii gets yanked from his comfy home planet and tossed into a...

Continue Reading
Capacity LLC: Finalist in 2026 BeautyMatter Awards

Updated Category News Views 25

A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...

Continue Reading
ALHC Faces Fraud Probe After 16% Stock Plummet

Updated Category News Views 28

Investors Eye Alignment's Tumultuous Turn One thing I don't do is sugarcoat it—stocks get hit hard sometimes, and Alignment Healthcare's recent saga has got jaws dropping across trading floors. It's only October, but Alignment's stock took a chilling nosedive on July 8, to the tune of 16.7%, leaving investors wide-eyed and demanding answers. What caused this seismic...

Continue Reading
Bladex Delivers Strong Q3 With $63M Net Profit

Updated Category News Views 63

Bladex Reports Impressive Q3 Profits Amid a sea of financial updates, Bladex's third-quarter numbers stand out like a lighthouse. They just flashed a $63.2 million net profit—up 15% from last year. That's the kind of growth that gets investors talking over their morning coffee. The magic behind these figures? Bladex managed to wrangle more revenue from net interest...

Continue Reading

Top 5 Most Recently Viewed Articles

Zenas BioPharma Class Action: Your Chance to Lead the Charge

Updated Category News Views 135

Opportunity to Lead Class Action Lawsuit for Zenas BioPharma Investors Investors of Zenas BioPharma, Inc. (NASDAQ: ZBIO) who have suffered substantial financial losses have a vital chance to become a lead plaintiff in an ongoing class action lawsuit. This opportunity stems from the registration statement connected to the company’s initial public offering (IPO)....

Continue Reading
Toyota Motor Adjusts EV Production Plans Amid Market Shifts

Updated Category News Views 173

Toyota Adjusts Its Production Strategies Toyota Motor Corporation (NYSE: TM) has recently faced a decline in its shares following the announcement of a major reduction in its electric vehicle production target for 2026. The company now aims to produce one million electric vehicles, which is a 30% decrease from its earlier forecast. This change is a response to a...

Continue Reading
Investors Urged to Explore Legal Options Against Fluence Energy

Updated Category News Views 363

Investors Encouraged to Take Action Against Fluence Energy Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating potential claims against Fluence Energy, Inc. (NASDAQ: FLNC). Recent market fluctuations have led to concerns that investors may have suffered significant financial losses. If you have incurred losses exceeding $75,000 in...

Continue Reading
Christopher A. DeNicola Takes Helm as CEO of Precision Spine

Updated Category News Views 215

Leadership Change at Precision Spine In a significant move, Precision Spine, Inc., a recognized leader in spinal pathology solutions, has announced the promotion of Christopher A. DeNicola to the role of President and Chief Executive Officer. This transition, which is effective immediately, places DeNicola in charge of guiding the company's strategic vision and...

Continue Reading
How Alliance Pharmaceuticals is Transforming Brand Protection

Updated Category News Views 120

Alliance Pharmaceuticals and TrueMed Forge New Partnership An innovative collaboration has emerged between Alliance Pharmaceuticals Ltd and TrueMed, aimed at tackling the ever-growing menace of counterfeit pharmaceuticals. This partnership leverages cutting-edge AI technology for efficient counterfeit detection, marking a significant shift in the operational landscape of...

Continue Reading